Alto Neuroscience, Inc. (ANRO)
24.48
+0.45
(+1.87%)
USD |
NYSE |
Oct 09, 14:37
Alto Neuroscience Net Income (Quarterly) : -27.64M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -27.64M |
| March 31, 2026 | -26.24M |
| December 31, 2025 | -16.18M |
| September 30, 2025 | -14.18M |
| June 30, 2025 | -17.71M |
| March 31, 2025 | -15.17M |
| December 31, 2024 | -15.20M |
| September 30, 2024 | -16.78M |
| Date | Value |
|---|---|
| June 30, 2024 | -16.03M |
| March 31, 2024 | -13.42M |
| December 31, 2023 | -11.22M |
| September 30, 2023 | -9.141M |
| June 30, 2023 | -8.663M |
| March 31, 2023 | -7.284M |
| December 31, 2022 | -7.652M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 23.00M |
| Corcept Therapeutics, Inc. | 42.14M |
| Veru, Inc. | -6.988M |
| Johnson & Johnson | 5.534B |
| Eli Lilly & Co. | 7.095B |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 27.64M |
| EPS Diluted (Quarterly) | -0.6456 |
| Enterprise Value | 622.87M |
| Earnings Yield | -10.10% |
| Normalized Earnings Yield | -10.06 |